Sign in
4

Changes in Ownership

SELLAS Life Sciences Group, Inc. Filed Acc 0001250853-14-000026

Director sold 450,000 shares at an average $6.52 ($2,932,500)

  • Director acquired 450,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

KRIEGSMAN STEVEN A · Director

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2014-01-17 Exercise or conversion : show line 1 in the form +200,000 $0.85 $170,000 205,000 D
2014-01-17 Sale : show line 2 in the form −200,000 $7.00 $1,400,000 5,000 D
2014-01-22 Exercise or conversion : show line 3 in the form +200,000 $1.18 $236,000 205,000 D
2014-01-22 Exercise or conversion : show line 4 in the form +50,000 $0.72 $36,000 255,000 D
2014-01-22 Sale : show line 5 in the form −250,000 $6.13 $1,532,500 5,000 D
Open-market sales · 450,000 sh · avg $6.52 · $2,932,500

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2014-01-17 Exercise or conversion : show line 6 in the form Stock Option (right to buy) −200,000 0 D
2014-01-22 Exercise or conversion : show line 7 in the form Stock Option (right to buy) −200,000 0 D
2014-01-22 Exercise or conversion : show line 8 in the form Stock Option (right to buy) −50,000 0 D
Loading xslF345X03/primary_doc.xml…